Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Ck-2017357
1. 1005491-05-3
2. Ck-2017357
3. Tirasemtiv(ck-2017357)
4. 6-ethynyl-1-(pentan-3-yl)-1h-imidazo[4,5-b]pyrazin-2-ol
5. 5-ethynyl-3-pentan-3-yl-1h-imidazo[4,5-b]pyrazin-2-one
6. Ck2017357
7. G8wsm7r635
8. 6-ethynyl-1-(pentan-3-yl)-2h-imidazo(4,5-b)pyrazin-2-one
9. 1-(1-ethylpropyl)-6-ethynyl-1,3-dihydro-2h-imidazo(4,5-b)pyrazin-2-one
10. 2h-imidazo(4,5-b)pyrazin-2-one, 1-(1-ethylpropyl)-6-ethynyl-1,3-dihydro-
11. 2h-imidazo[4,5-b]pyrazin-2-one, 1-(1-ethylpropyl)-6-ethynyl-1,3-dihydro-;2h-imidazo[4,5-b]pyrazin-2-one, 1-(1-ethylpropyl)-6-ethynyl-1,3-dihydro-
12. Tirasemtiv [inn]
13. Tirasemtiv (usan/inn)
14. Tirasemtiv [usan:inn]
15. Unii-g8wsm7r635
16. Ck 2017357
17. 1-(1-ethylpropyl)-6-ethynyl-1,3-dihydro-2h-imidazo[4,5-b]pyrazin-2-one
18. Tirasemtiv (ck-2017357)
19. Tirasemtiv [usan]
20. Tirasemtiv [who-dd]
21. Schembl976988
22. Gtpl8280
23. Chembl3039529
24. Dtxsid90143379
25. Ex-a367
26. Bcp27991
27. Bdbm50316148
28. Mfcd28023588
29. Zinc95627912
30. Akos027250724
31. Db12209
32. Sb16955
33. Ncgc00378555-02
34. Ac-35962
35. Bs-22417
36. Da-48425
37. Hy-15964
38. Ft-0746303
39. S0196
40. D10327
41. A898831
42. Q27088998
43. Ck2017357; Ck-2017357; Ck 2017357
44. 6-ethynyl-1-(pentan-3-yl)-1h-imidazo[4,5-b]pyrazin-2(3h)-one
45. 6-ethynyl-1-(pentan-3-yl)-1,3-dihydro-2h-imidazo[4,5-b]pyrazin-2-one
46. W97
| Molecular Weight | 230.27 g/mol |
|---|---|
| Molecular Formula | C12H14N4O |
| XLogP3 | 1.4 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 4 |
| Exact Mass | 230.11676108 g/mol |
| Monoisotopic Mass | 230.11676108 g/mol |
| Topological Polar Surface Area | 58.1 Ų |
| Heavy Atom Count | 17 |
| Formal Charge | 0 |
| Complexity | 344 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Treatment of amyotrophic lateral sclerosis
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
58
PharmaCompass offers a list of Tirasemtiv API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Tirasemtiv manufacturer or Tirasemtiv supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Tirasemtiv manufacturer or Tirasemtiv supplier.
PharmaCompass also assists you with knowing the Tirasemtiv API Price utilized in the formulation of products. Tirasemtiv API Price is not always fixed or binding as the Tirasemtiv Price is obtained through a variety of data sources. The Tirasemtiv Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Tirasemtiv manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tirasemtiv, including repackagers and relabelers. The FDA regulates Tirasemtiv manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tirasemtiv API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Tirasemtiv supplier is an individual or a company that provides Tirasemtiv active pharmaceutical ingredient (API) or Tirasemtiv finished formulations upon request. The Tirasemtiv suppliers may include Tirasemtiv API manufacturers, exporters, distributors and traders.
Tirasemtiv Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tirasemtiv GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tirasemtiv GMP manufacturer or Tirasemtiv GMP API supplier for your needs.
A Tirasemtiv CoA (Certificate of Analysis) is a formal document that attests to Tirasemtiv's compliance with Tirasemtiv specifications and serves as a tool for batch-level quality control.
Tirasemtiv CoA mostly includes findings from lab analyses of a specific batch. For each Tirasemtiv CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tirasemtiv may be tested according to a variety of international standards, such as European Pharmacopoeia (Tirasemtiv EP), Tirasemtiv JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tirasemtiv USP).
